| Literature DB >> 28538881 |
Hassanain Al-Talib1, Alyaa Al-Khateeb2, Ayad Hameed3, Chandrika Murugaiah4.
Abstract
Acne vulgaris is an extremely common condition affecting the pilosebaceous unit of the skin and characterized by presence of comedones, papules, pustules, nodules, cysts, which might result in permanent scars. Acne vulgaris commonly involve adolescents and young age groups. Active acne vulgaris is usually associated with several complications like hyper or hypopigmentation, scar formation and skin disfigurement. Previous studies have targeted the efficiency and safety of local and systemic agents in the treatment of active acne vulgaris. Superficial chemical peeling is a skin-wounding procedure which might cause some potentially undesirable adverse events. This study was conducted to review the efficacy and safety of superficial chemical peeling in the treatment of active acne vulgaris. It is a structured review of an earlier seven articles meeting the inclusion and exclusion criteria. The clinical assessments were based on pretreatment and post-treatment comparisons and the role of superficial chemical peeling in reduction of papules, pustules and comedones in active acne vulgaris. This study showed that almost all patients tolerated well the chemical peeling procedures despite a mild discomfort, burning, irritation and erythema have been reported; also the incidence of major adverse events was very low and easily manageable. In conclusion, chemical peeling with glycolic acid is a well-tolerated and safe treatment modality in active acne vulgaris while salicylic acid peels is a more convenient for treatment of darker skin patients and it showed significant and earlier improvement than glycolic acid.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28538881 PMCID: PMC5429107 DOI: 10.1590/abd1806-4841.20175273
Source DB: PubMed Journal: An Bras Dermatol ISSN: 0365-0596 Impact factor: 1.896
Summary of literature search
| Database | Key words | No. of abstract retrieved | No. of an article selected |
|---|---|---|---|
| PubMed | (1) Active acne vulgaris | 219 | - |
| (2) Superficial chemical peels | 65 | 4 | |
| (1) e ( 2) | 2 | 1 | |
| Google Scholar | (1) Active acne vulgaris | 14.700 | - |
| (2) Superficial chemical peels | 16.400 | - | |
| (1) e (2) | 1.170 | 2 |
Study population with efficacy and adverse effects of chemical peels
| Kessler, et | N= 20, American patients, (13-35) | Both GA and SA peels were significantly | Safety peeling for both GA and SA, mild |
| Hashimoto | N= 16, Japanese patients, (16-29) | Comedones are reduced to 75%. The mean | Mild burning sensation and erythema were |
| Dainichi et | N = 436, Japanese patient, (17-46) | Comedones are significant improvement | No complaints of pain, burning, or stinging |
| Garg et al., | N = 44, Indian patients, (16 -27) | Both GA and SA peels decrease the comedones; | Adverse effects were less common with |
| Dréno et al., | N = 397, pacientes com (30-40) | Inflammatory and retentional lesions were | Adverse effects were infrequent with some |
| Kim et al., | N = 26, Korean patients; (16 - 27) | After the first treatment session, the severity | More adverse effects seen by Jessner's |
| Atzori et al., | N = 80, Italian patients (16 - 27) | Rapid improvement was observed in comedonic | A minimal inflammatory lesions developed |
Chemical peeling and post - peeling assessments
| Kessler, et | GA 30%, SA 30% | Double-blind, randomized controlled study, prospective, split-face. |
| al., 2008 ([ | Quantitative and qualitative assessment was done based on the number of papules and pustules | |
| Clinical response was graded as: | ||
| Good > 50% improvement. | ||
| Satisfactory (21%-50%) | ||
| Poor (10%-20%) | ||
| No change | ||
| Worsening | ||
| Hashimoto | SA 30% | Open-label trial, ten weeks study. |
| et al.,2008 | Clinical response was assessed by both changes in severity and comedone count reduction rate. | |
| ([ | ||
| Dainichi et | SA 30 % -PEG | Open-label trial, non-specific peeling number, |
| al.,2008 ([ | Assessments by a questionnaire on adverse effects and efficacy of the peeling, which was filled | |
| out by patients. The evaluation scores for each question were divided into five answer categories: | ||
| Not at all: 0%. | ||
| Little: 0% to 25%. | ||
| Some: 25% to 50%. | ||
| Quite a lot: 50% to 75%. | ||
| Very much: 75% to 100%. | ||
| Garg et al., | GA 35%, SA 20% -mandelic | Open-label trial, comparative study. |
| 2009 ([ | acid 10% peels | Pre-treatment assessments of acne lesion was done by Michaelson method, |
| Post- treatment assessment of the response on a 5-point visual analog scale: | ||
| Good > 60%. | ||
| Satisfactory 31 - 60%. | ||
| Poor < 30%. | ||
| No change | ||
| Worsening | ||
| Dréno et al., | RAL 0.1%, GA 6% | Open-label trial, |
| 2011([ | Efficacy of treatment was assessed by counting inflammatory lesions (papules & pustules) and | |
| retentional lesions (open and closed comedones) on days 30 and 90 using a 5-grade rating scale: | ||
| 0 = no improvement. | ||
| 1 = mild improvement. | ||
| 2 = moderate improvement. | ||
| 3 = notable improvement. | ||
| 4 = very notable improvement. | ||
| Kim et al., | GA 70%, Jessner's | A randomized prospective clinical trial of split-face model therapy was done. |
| 1999 ([ | solution | Skin lesions were graded by using Cunliffe's acne grading system based on depth and width of |
| acne lesions. | ||
| 0.25: a few small inflamed lesions. | ||
| 0.5: small inflammatory lesions over a wider area. | ||
| 1.0: more intensely inflamed. | ||
| 1.5: intensely inflamed lesions over a wider area. | ||
| 2.0: deeper lesions but not nodular. | ||
| Atzori et al., | GA 70% | Open-label trial, the procedure was well tolerated and patient compliance was excellent when |
| 1999 [ | asked to evaluate their skin. | |
| Assessments by patient opinion and clinical rating based on this scale: | ||
| Mild improvement. | ||
| Moderate improvement. | ||
| Marked improvement. | ||
| Worsening. | ||
| 95% of the patients reported marked improvement, while the rest reported a moderate effect. |
SA-PEG : Salicylic acid in polyethylene glycol, GA; Glycolic acid, RAL; Retinaldehyde, SA; Salicylic acid.